![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
REVERSIBILITY OF TAF- AND/OR INSTI-ASSOCIATED WEIGHT GAIN
|
|
|
CROI 2023 Feb 20-23
Myrthe L. Verburgh1,2,3, Ferdinand W.N.M. Wit1,2,4, Anders Boyd4,5, Peter Reiss1,2,3,6 and Marc van der Valk1,2,4; for the ATHENA HIV observational cohort study
1 Amsterdam UMC location University of Amsterdam, Infectious Diseases, Amsterdam, The Netherlands; 2 Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands; 3 Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands; 4 HIV Monitoring Foundation, Amsterdam, The Netherlands; 5 Public Health Service of Amsterdam, Infectious Diseases, Amsterdam, The Netherlands; 6 Amsterdam UMC location University of Amsterdam, Global Health, Amsterdam, The Netherlands
![0224231](../images/022523/022523-6/0224231.gif)
![0224232](../images/022523/022523-6/0224232.gif)
![0224233](../images/022523/022523-6/0224233.gif)
![0224234](../images/022523/022523-6/0224234.gif)
![0224235](../images/022523/022523-6/0224235.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|